
Pharma News
-
Pfizer and BioNTech announce publication of results from landmark Phase 3 trial
2020-12-23Pfizer Inc.and BioNTech SE announced that the New England Journal of Medicine has published safety and final efficacy results from the pivotal Phase 3 trial of BNT162b2, their mRNA-based COVID-19 vaccine candidate.
-
Sanofi and GSK announced the postponement of their adjuvant recombinant protein-
2020-12-23Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in older adults. Phase 1/2 study interim results showed an immune response comparable to patients who recovered from COVID-19
-
FDA takes key action in fight against COVID-19 by issuing Emergency Use Authoriz
2020-12-23The U.S. Food and Drug Administration issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years
-
Novartis provides update on RUXCOVID study of ruxolitinib for hospitalized patie
2020-12-23Novartis today announced that the Phase III RUXCOVID study evaluating ruxolitinib on top of standard of care (SoC) therapy compared to SoC treatment alone in patients with COVID-19 did not meet its primary endpoint.
-
2020-2025 China Ibuprofen API Market Report
2020-12-21Ibuprofen is also known as ibuprofen and its chemical name is 2-(4-isobutylphenyl)propionic acid. It is a new generation of non-steroidal anti-inflammatory and analgesic drugs, suitable for the treatment of rheumatoid arthritis and rheumatoid arthritis.
-
The heavy pharmaceutical policy is about to be implemented
2020-12-18The new "Chinese Pharmacopoeia" is published in four parts and contains 5911 varieties, including 319 new varieties and 3177 revised products. The industry generally believes that the promulgation and implementation of the new version of the Pha
-
Export of raw materials to India may face greater challenges
2020-12-17As China's largest export destination country for APIs, India accounts for 17% of China's total API exports. According to reports, 70% of the APIs needed by India come from China
-
Forecast of TOP 10 global best-selling drugs in 2021
2020-12-15On December 11, Nature Reviews Drug Discovery published its 2021 global best-selling drug TOP10 forecast (as shown below). The cumulative sales revenue of these 10 drugs in 2021 will reach 109.75 billion U.S. dollars.
-
Antidiabetic drugs are involved in the 'price reduction' storm!
2020-12-14On December 9, a "Notice on Reporting the Purchasing Data of the Fourth Batch of National Organizations for Centralized Procurement of Drugs" was released in the industry.
-
Novartis siRNA Therapy Receives EU Marketing Approval
2020-12-14Novartis announced on the 12th that its siRNA therapy Leqvio (inclisiran) has been approved by the European Commission for the treatment of adult hypercholesterolemia and mixed dyslipidemia.
-
Oral drug blocks SARS-CoV-2 transmission
2020-12-14Treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours, researchers in the Institute for Biomedical Sciences at Georgia State University have discovered.
-
Moderna announces first participants dosed in Phase 2/3 study of COVID-19 vaccin
2020-12-14Moderna Inc. today announced that the first adolescent participants have been dosed in the Phase 2/3 study of mRNA-1273, the Company’s vaccine candidate against COVID-19, in adolescents ages 12 to less than 18.
-
J&J trims the size of its phase 3 COVID-19 vaccine trial
2020-12-14Johnson & Johnson (J&J) announced on Wednesday that it will decrease the size of its US-based phase 3 trial currently testing its COVID-19 vaccine as cases surge across the country.
-
FDA expert panel recommends EUA for Pfizer/BioNTech COVID-19 vaccine
2020-12-14A US Food and Drug Administration (FDA) advisory committee panel recommended Pfizer/BioNTech’s COVID-19 vaccine for emergency use following an hours long meeting held yesterday.
-
Quaternary ammonium salt disinfectants in China
2020-12-10With the outbreak of the new coronavirus pneumonia in early 2020, "disinfection and sterilization" has almost become a daily necessity, and the supply of disinfectant products is also in short supply.
-
Inching toward first-in-class new drugs
2020-12-08When I started reporting on healthcare around 10 year ago, domestic drugs for cancer treatment were often seen as being less effective than foreign medicine.
-
Sinovac secures $500 million in funding for COVID-19 vaccine development
2020-12-08Sinovac Biotech Ltd, a leading provider of biopharmaceutical products in China, announced Monday that Sinovac Life Sciences Co Ltd
-
Top 1000 global pharmaceutical companies are released, China has 208
2020-12-08Recently, the global investment bank Torreya released the "Global Top 1000 Pharmaceutical Companies Report". The report conducted a tracking study of 30,000 pharmaceutical companies around the world since 2012, and finally released the TOP1000 r
-
Export of APIs may benefit Biden's victory
2020-12-07The United States ranks second in my country's list of export destinations for APIs. From 2017 to 2018, my country's export of APIs to the United States achieved rapid growth, with year-on-year growth rates reaching 23.84% and 8.87% respectively.
-
Kangfang bio-targeting IL-4R new drug approved clinically in the United States
2020-12-02On December 1, Kangfang Bio announced its independent research and development of the innovative drug AK120, which was approved by the FDA to carry out a phase 1b clinical study for the treatment of moderate to severe atopic dermatitis in the United State
-
Pharmaceutical Industry Overview
The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.Published in: Aug. 2024
Hot News
-
Top 10 Global CDMO Rankings in 2022
-
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody
-
Forecast of TOP 10 global best-selling drugs in 2021
-
Lilly's GLP-1 and Tirzepatide initiates phase III clinical trial
-
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
-
China State Drug Administration officially approved Semaglutide for type 2 diabetes
-
Top 30 best-selling oncology drugs in the world in 2020
-
Breaking News! China's First KRAS G12D Inhibitor Approved for Clinical Use
-
Pfizer and BioNTech propose expansion of pivotal COVID-19 vaccine trial
-
AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan